Published in Br J Clin Pharmacol on March 01, 1982
Renal and immunological effects of occupational exposure to inorganic mercury. Br J Ind Med (1992) 1.09
THE MEASUREMENT OF THE TUBULAR EXCRETORY MASS, EFFECTIVE BLOOD FLOW AND FILTRATION RATE IN THE NORMAL HUMAN KIDNEY. J Clin Invest (1938) 56.55
THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN. J Clin Invest (1945) 27.11
RELATIONS OF EFFECTIVE RENAL BLOOD FLOW AND GLOMERULAR FILTRATION TO TUBULAR EXCRETORY MASS IN NORMAL MAN. J Clin Invest (1940) 17.26
Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest (1950) 9.22
The excretion of acid in renal disease. Q J Med (1959) 6.43
Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci (1969) 5.26
The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol (1976) 3.51
Acute interstitial nephritis due to methicillin. Am J Med (1978) 2.11
High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis. Cancer (1977) 2.07
Evidence of gentamicin nephrotoxicity in patients with renal allografts. Br Med J (1975) 2.05
Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein. J Clin Invest (1969) 1.97
Reduction of renal function by newer nonsteroidal anti-inflammatory drugs. Am J Med (1978) 1.96
Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease. Pediatrics (1978) 1.58
Creatininemia versus uremia. The relative significance of blood urea nitrogen and serum creatinine concentrations in azotemia. Ann Intern Med (1966) 1.56
Renal irritation caused by salicylates. Lancet (1963) 1.52
Gentamicin tissue accumulation and nephrotoxic reactions. JAMA (1978) 1.49
The effect of indomethacin on kidney function and plasma renin activity in man. Nephron (1976) 1.42
Assessment of renal concentrating ability. Br Med J (1979) 1.40
Short-term study of the effect of phenacetin, phenazone and amidopyrine on the rat kidney. Br J Pharmacol Chemother (1968) 1.29
Vasopressin tannate in oil and the urine concentration test. Lancet (1956) 1.28
Renal damage caused by gentamicin: a study of the effects on renal morphology and urinary enzyme excretion. J Pathol (1976) 1.24
Molecular basis for several drug-induced nephropathies. Am J Med (1977) 1.18
The excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase following surgery to the kidney. Clin Chim Acta (1970) 1.18
Renal function in analgesic nephropathy. Br Med J (1969) 1.17
The excretion of renal cells following necrosis of the proximal convoluted tubule. Br J Exp Pathol (1967) 1.10
Effect of aminoglycosides on proximal tubular membranes of the human kidney. Eur J Clin Pharmacol (1978) 1.09
The use of urinary enzyme measurements to detect renal damage caused by nephrotoxic compounds. Biochem Pharmacol (1974) 1.05
Urinary beta 2 microglobulin in upper and lower urinary-tract infections. Lancet (1979) 0.99
Glomerular filtration rate and creatinine clearance. Br J Clin Pharmacol (1981) 0.98
RENAL TESTS IN TOXICITY STUDIES ON RATS. Toxicol Appl Pharmacol (1963) 0.93
Pseudoproteinuria in tolmetin-treated patients. Clin Pharmacol Ther (1975) 0.92
Enzymes of renal origin in urine as indicators of nephrotoxicity. Toxicol Appl Pharmacol (1977) 0.90
Mitigation of amphotericin B nephrotoxicity by mannitol. Br Med J (1975) 0.87
[Urinary enzymes following medicamentous stimulation of the kidney using salicylate]. Schweiz Med Wochenschr (1967) 0.87
Radiological changes of renal papillary necrosis. Kidney Int (1978) 0.87
AMINOACIDURIA INDUCED BY SALICYLATES. J Lab Clin Med (1964) 0.84
Renal handling of beta2-microglobulin in experimental renal disease. Scand J Clin Lab Invest (1975) 0.84
Diagnostic value of urinary enzyme determinations. Clin Chem (1972) 0.83
Chronic effect of analgesics on the kidney. Prog Biochem Pharmacol (1972) 0.82
The excretion of lacate dehydrogenase in human urine after he ingestion of aspiin. Biochem J (1969) 0.82
Origin of urinary enzymes hydrolysing beta-naphthylamides of L-leucine and L-glutamic acid. Clin Chim Acta (1968) 0.82
Interstitial nephritis in a case of phenylbutazone hypersensitivity. Br Med J (1978) 0.80
Acetylsalicylic acid and the kidneys. Helv Med Acta (1969) 0.80
Effects of drugs on water metabolism. Br J Clin Pharmacol (1981) 0.79
Renal function in lithium and non-lithium treated patients with affective disorders. Acta Psychiatr Scand (1980) 0.79
Salicylate-induced enzymuria: comparison with other anti-inflammatory agents. Am J Med (1978) 0.78
Analgesic nephropathy and the renal concentrating mechanism. Pathol Annu (1977) 0.78
beta2 microglobulinuria in a patient with nephrotoxicity secondary to mercuric chloride ingestion. Clin Toxicol (1977) 0.78
Effect of frusemide, lactose, and urea on urinary cell loss. Br Med J (1968) 0.77
Polyuric renal failure and hepatitis: associated with methoxyflurane anesthesia. N Y State J Med (1977) 0.76
Identification of cells exfoliated from the rat kidney in experimental nephrotoxicity. Ann Rheum Dis (1970) 0.76
Decreased nephrotoxic effect of mercuric chloride on the regenerating kidneys [proceedings]. Br J Pharmacol (1979) 0.76
Membranous glomerulopathy in a patient on captopril. Acta Med Scand (1980) 0.76
Renal function and morphology in long-term lithium and combined lithium-neuroleptic treatment. Acta Med Scand (1980) 0.76
Frusemide and renal enzyme excretion. Br Med J (1978) 0.76
[Changes of Hippuran renographic curve following the use of phenylbutazone, Spofa]. Vnitr Lek (1971) 0.76
[Influence of urinary pH on the activity of urinary enzymes]. Experientia (1967) 0.76
Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J (1979) 6.45
Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet (1971) 4.40
Successful treatment of severe paracetamol overdosage with cysteamine. Lancet (1974) 3.83
Mefenamic acid nephropathy. Lancet (1980) 3.80
Pharmacological modification of gastric emptying: effects of propantheline and metoclopromide on paracetamol absorption. Br Med J (1973) 3.77
Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning. Lancet (1976) 3.41
Should methionine be added to every paracetamol tablet? BMJ (1997) 3.33
The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmacol (1973) 3.26
Treatment of drug overdosage with naloxone, a specific narcotic antagonist. Lancet (1973) 3.16
Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet (1977) 3.00
Treatment of salicylate poisoning with repeated oral charcoal. Br Med J (Clin Res Ed) (1985) 2.90
Diuresis or urinary alkalinisation for salicylate poisoning? Br Med J (Clin Res Ed) (1982) 2.90
Liver damage and impaired glucose tolerance after paracetamol overdosage. Br Med J (1966) 2.68
Kinetics of acetaminophen absorption and gastric emptying in man. Clin Pharmacol Ther (1978) 2.41
Rapid gas-liquid chromatographic estimation of antipyrine in plasma. J Pharm Pharmacol (1973) 2.31
Narcotic analgesics and delayed gastric emptying during labour. Lancet (1975) 2.24
Inhibition of gastric emptying and drug absorption by narcotic analgesics. Br J Clin Pharmacol (1975) 2.18
Gas-liquid chromatographic estimation of paracetamol. J Pharm Pharmacol (1971) 2.16
Pharmacokinetic drug interactions. Lancet (1969) 2.07
Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol. Lancet (1979) 2.06
Treatment of ventricular arrhythmias with mexiletine (Kö 1173). Lancet (1973) 2.04
Henry Matthew: the father of modern clinical toxicology. J R Coll Physicians Edinb (2009) 2.04
The chief scientist reports ... prevention of hepatic necrosis following paracetamol overdosage. Health Bull (Edinb) (1978) 2.03
Paracetamol metabolism following overdosage: application of high performance liquid chromatography. J Pharm Pharmacol (1977) 2.01
Acute haemolysis and renal failure after nomifensine overdosage. Br Med J (1980) 2.00
Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol (1980) 1.87
Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology (1997) 1.87
High performance liquid chromatographic estimation of paracetamol metabolites in plasma. Br J Clin Pharmacol (1978) 1.78
Absorption, distribution and elimination of mexiletine. Postgrad Med J (1977) 1.74
Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs (1983) 1.70
Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination. Q J Med (1985) 1.65
Paracetamol (acetaminophen) poisoning. No need to change current guidelines to accident departments. BMJ (1998) 1.57
Generic inequivalence--clinical observations. Acta Pharmacol Toxicol (Copenh) (1971) 1.55
Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet (1982) 1.54
Effects of non-narcotic analgesics on the liver. Drugs (1986) 1.50
Gastrointestinal absorption of drugs. Med Clin North Am (1974) 1.49
Inter-subject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol (1986) 1.48
Drugs prescribed for self poisoners. Br Med J (Clin Res Ed) (1985) 1.44
Analgesic abuse and renal disease in North-East Scotland. Lancet (1966) 1.40
Paracetamol and aspirin absorption from Safapryn and Safapryn-Co. Br J Clin Pharmacol (1979) 1.39
Renal papillary necrosis and aspirin. Scott Med J (1969) 1.38
Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine. J Pharm Pharmacol (1973) 1.36
Long-term treatment of ventricular arrhythmias with oral mexiletine. Am Heart J (1976) 1.36
The gas-liquid chromatographic estimation of phenacetin and paracetamol in plasma and urine. J Pharm Pharmacol (1971) 1.29
Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal. Q J Med (1986) 1.26
Death and blindness due to overdose of quinine. Br Med J (Clin Res Ed) (1985) 1.25
Potentiation by previous drug therapy of hepatotoxicity following paracetamol overdosage. Scott Med J (1973) 1.25
Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction. Lancet (1975) 1.25
Why do patients still die from paracetamol poisoning? Br Med J (Clin Res Ed) (1986) 1.25
The treatment of acetaminophen poisoning. Annu Rev Pharmacol Toxicol (1983) 1.24
Fatal pulmonary aspiration of oral activated charcoal. BMJ (1988) 1.24
A pharmacokinetic study of doxapram in patients and volunteers. Br J Clin Pharmacol (1979) 1.22
Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure. Br Med J (1976) 1.20
Treatment of severe 2,4-D and mecoprop intoxication with alkaline diuresis. Br J Clin Pharmacol (1979) 1.19
New approaches in managing drug overdosage and poisoning. Br Med J (Clin Res Ed) (1983) 1.15
Fulminant hyperkalaemia and multiple complications following ibuprofen overdose. Med Toxicol Adverse Drug Exp (1990) 1.15
The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man. Br J Clin Pharmacol (1984) 1.14
Rapid gas--liquid chromatographic estimation of doxapram in plasma. J Chromatogr (1977) 1.14
Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics. Drugs (1982) 1.14
Effects of microsomal enzyme induction on paracetamol metabolism in man. Br J Clin Pharmacol (1981) 1.12
Treatment of severe acetaminophen poisoning with intravenous acetylcysteine. Arch Intern Med (1981) 1.11
SI, moles, and drugs. Br Med J (1978) 1.09
Mefenamic acid overdosage. Lancet (1981) 1.09
The effects of repeated administration of mercuric chloride on exfoliation of renal tubular cells and urinary glutamic-oxaloacetic transaminase activity in the rat. Toxicol Appl Pharmacol (1969) 1.09
Who needs molar units for drugs? Lancet (1987) 1.07
The ventilatory effects of doxapram in normal man. Clin Sci (Lond) (1983) 1.07
Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease. Br Med J (1977) 1.06
Inadequate information about drug overdosage in manufacturers' data sheets. Br Med J (1980) 1.05
The effects of particle size on the absorption of phenacetin in man. A correlation between plasma concentration of phenacetin and effects on the central nervous system. Clin Pharmacol Ther (1970) 1.05
The effects of hepatic and renal damage on paracetamol metabolism and excretion following overdosage. A pharmacokinetic study. Br J Pharmacol (1973) 1.04
Changes in cardiorespiratory function during gastric lavage for drug overdose. Hum Toxicol (1987) 1.03
Inappropriate methods for the emergency determination of plasma paracetamol. Ann Clin Biochem (1979) 1.02
Data point weighting in pharmacokinetic analysis: intravenous paracetamol in man. J Pharm Pharmacol (1976) 1.01
Paracetamol metabolism in chronic liver disease. Eur J Clin Pharmacol (1979) 0.99
Clinically important drug interactions. Drugs (1973) 0.99
Americans retreat on SI units. BMJ (1992) 0.98
The nephrotoxicity of analgesics. J Pharm Pharmacol (1966) 0.97
Gastric emptying and drug absorption. Br J Clin Pharmacol (1974) 0.97
Impaired absorption and metabolism of oral lignocaine in patients undergoing laparoscopy. Br J Anaesth (1973) 0.96
Paracetamol metabolites in the neonate following maternal overdose. Br J Clin Pharmacol (1984) 0.95
Is there a place for cimetidine or ethanol in the treatment of paracetamol poisoning? Lancet (1983) 0.94
Panel discussion. Management of acetaminophen overdose. Arch Intern Med (1981) 0.94
Gas-liquid chromatographic estimation of tolbutamide and chlorpropamide in plasma. J Pharm Pharmacol (1972) 0.94
Experimental paracetamol-induced hepatic necrosis: a histopathological study. J Pathol (1971) 0.94
Premedication for upper gastrointestinal endoscopy: a comparative study of flunitrazepam, diazepam and neuroleptanalgesia. Endoscopy (1978) 0.93
The absorption of aspirin and paracetamol in patients with achlorhydria. J Pharm Pharmacol (1974) 0.92
Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning. Br Med J (1980) 0.92
Drug interactions affecting analgesic toxicity. Am J Med (1983) 0.92
Gross impairment of hepatic drug metabolism in a patient with chronic liver disease. Br Med J (1974) 0.91
Combined clinical and metabolic study of the effects of alpha-methyldopa on hypertensive patients. Circulation (1966) 0.91
Hepatotoxicity of mild analgesics. Br J Clin Pharmacol (1980) 0.90
The disposition of intravenous doxapram in man. Eur J Clin Pharmacol (1979) 0.90
The comparative metabolism of phenacetin and N-acetyl-p-aminophenol in man, with particular reference to effects on the kidney. Clin Pharmacol Ther (1968) 0.89
Gas-liquid chromatographic estimation of lignocaine, ethylglycylxylidide, glycylxylidide and 4-hydroxyxylidine in plasma and urine. J Pharm Pharmacol (1974) 0.89
Paracetamol-induced acute renal failure in the absence of fulminant liver damage. Br Med J (Clin Res Ed) (1982) 0.88
Abnormal drug metabolism after barbiturate and paracetamol overdose. Br Med J (1974) 0.88
Dose-dependent absorption and elimination of cefadroxil in man. Eur J Clin Pharmacol (1991) 0.88
Paracetamol pharmacokinetics in thyroid disease. Eur J Clin Pharmacol (1980) 0.88
Effect of food on the absorption of frusemide and bumetanide in man. Br J Clin Pharmacol (1996) 0.87
Acetaminophen absorption and metabolism in celiac disease and Crohn's disease. Clin Pharmacol Ther (1981) 0.87